Your browser doesn't support javascript.
loading
A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia.
Short, Nicholas J; Kantarjian, Hagop; Ravandi, Farhad; Huang, Xuelin; Xiao, Lianchun; Garcia-Manero, Guillermo; Plunkett, William; Gandhi, Varsha; Sasaki, Koji; Pemmaraju, Naveen; Daver, Naval G; Borthakur, Gautam; Jain, Nitin; Konopleva, Marina; Estrov, Zeev; Kadia, Tapan M; Wierda, William G; DiNardo, Courtney D; Brandt, Mark; O'Brien, Susan M; Cortes, Jorge E; Jabbour, Elias.
Afiliação
  • Short NJ; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Kantarjian H; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Ravandi F; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Huang X; b Department of Biostatistics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Xiao L; b Department of Biostatistics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Garcia-Manero G; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Plunkett W; c Department of Experimental Therapeutics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Gandhi V; c Department of Experimental Therapeutics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Sasaki K; d Division of Cancer Medicine , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Pemmaraju N; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Daver NG; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Borthakur G; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Jain N; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Konopleva M; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Estrov Z; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Kadia TM; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Wierda WG; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • DiNardo CD; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Brandt M; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • O'Brien SM; c Department of Experimental Therapeutics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Cortes JE; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
  • Jabbour E; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
Leuk Lymphoma ; 59(4): 813-820, 2018 04.
Article em En | MEDLINE | ID: mdl-28718728
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vidarabina / Idarubicina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Citarabina / Clofarabina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vidarabina / Idarubicina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Citarabina / Clofarabina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos